ReShape Lifesciences Inc. financial data

Symbol
RSLS on Nasdaq
Location
1001 Calle Amanecer, San Clemente, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 67.5 % -66.9%
Quick Ratio 51.1 % -44%
Debt-to-equity -369 % -0.33%
Return On Equity 488 % +315%
Return On Assets -300 % -167%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.64M shares +692%
Common Stock, Shares, Outstanding 133K shares -99.4%
Entity Public Float 5.64M USD +11.1%
Common Stock, Value, Issued 5.56K USD
Weighted Average Number of Shares Outstanding, Basic 2.76M shares +615%
Weighted Average Number of Shares Outstanding, Diluted 2.76M shares +615%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 34.6K USD -59%
Revenue from Contract with Customer, Excluding Assessed Tax 6.45M USD -19.8%
Research and Development Expense 1.73M USD +2.61%
Selling and Marketing Expense 583K USD -13%
General and Administrative Expense 6.37M USD -14.3%
Operating Income (Loss) -16.7M USD -160%
Nonoperating Income (Expense) -21K USD +92.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.47M USD +50.1%
Income Tax Expense (Benefit) 25K USD -60.3%
Net Income (Loss) Attributable to Parent -12.4M USD -105%
Earnings Per Share, Basic 1.65K USD/shares +99.8%
Earnings Per Share, Diluted 1.65K USD/shares +99.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.71M USD +668%
Accounts Receivable, after Allowance for Credit Loss, Current 23K USD -98.2%
Inventory, Net 2.55M USD -21.4%
Other Assets, Current 92.4K USD +81.2%
Assets, Current 6.04M USD +13.1%
Deferred Income Tax Assets, Net 28K USD +3.7%
Property, Plant and Equipment, Net 50.2K USD +16.7%
Operating Lease, Right-of-Use Asset 36.9K USD -79.2%
Intangible Assets, Net (Excluding Goodwill) 314K USD
Other Assets, Noncurrent 29K USD 0%
Assets 7.05M USD +451%
Accounts Payable, Current 1.65M USD -21.4%
Employee-related Liabilities, Current 907K USD +29.2%
Accrued Liabilities, Current 249K USD -84.8%
Liabilities, Current 3.12M USD -22.5%
Operating Lease, Liability, Noncurrent 8.15K USD -89.4%
Liabilities 3.13M USD -24.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -68.4K USD +22.3%
Retained Earnings (Accumulated Deficit) -86.3M USD +86.5%
Stockholders' Equity Attributable to Parent 2.53M USD +70.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.92M USD
Liabilities and Equity 7.05M USD +25.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.12M USD -2.27%
Net Cash Provided by (Used in) Financing Activities 3.95M USD
Net Cash Provided by (Used in) Investing Activities -7K USD -100%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 133K shares -99.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.82M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.71M USD +11577%
Deferred Tax Assets, Valuation Allowance 79.9M USD +3.85%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 79.9M USD +3.8%
Operating Lease, Liability 47.1K USD -78.2%
Depreciation 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.6M USD -109%
Lessee, Operating Lease, Liability, to be Paid 49.8K USD -78.4%
Property, Plant and Equipment, Gross 588K USD
Operating Lease, Liability, Current 30.5K USD -73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 59K USD -48.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 34K USD -70.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.5%
Deferred Income Tax Expense (Benefit) -4K USD -500%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.75K USD -81.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 59K USD
Deferred Tax Assets, Operating Loss Carryforwards 71.9M USD +5.85%
Preferred Stock, Shares Issued 3.08K shares
Preferred Stock, Shares Authorized 16M shares 0%
Unrecognized Tax Benefits 1.05M USD 0%
Operating Lease, Payments 28K USD +3.7%
Additional Paid in Capital 88.9M USD -86.2%
Preferred Stock, Shares Outstanding 3.08K shares
Amortization of Intangible Assets 33K USD -98.2%
Deferred Tax Assets, Net of Valuation Allowance 57K USD -38%
Share-based Payment Arrangement, Expense 616K USD +120%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares